VYXEOS LIPOSOMAL

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Romania, United Kingdom, United States

Active ingredients

The drug VYXEOS LIPOSOMAL contains a combination of these active pharmaceutical ingredients (APIs):

1 Daunorubicin UNII ZS7284E0ZP - DAUNORUBICIN

Daunorubicin is an anthracycline glycoside antibiotic and is a potent antileukaemic agent. It also has immunosuppressant effects. Daunorubicin may involve binding to DNA by intercalation between base pairs and inhibition of DNA and RNA synthesis by template disordering and steric obstruction. Read about Daunorubicin

2 Cytarabine UNII 04079A1RDZ - CYTARABINE

Cytarabine (ARA-C) is metabolised in vivo to ARA-CTP phosphorylated compound. This competitively inhibits DNA polymerase and may also inhibit certain acid kinase enzymes. Read about Cytarabine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
VYXEOS LIPOSOMAL Powder for concentrate for solution for infusion		MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XY01		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XY Combinations of antineoplastic agents
Discover more medicines within L01XY01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1778362, 1778373, 1778384
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181308001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 063574
Country: FR	Base de données publique des médicaments	Identifier(s): 63280448
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 357784
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9041
Country: IT	Agenzia del Farmaco	Identifier(s): 046965012, 046965024, 046965036
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086210, 1086211, 1086212
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100410692
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68462001, W68462002, W68462003, W69088001
Country: US	FDA, National Drug Code	Identifier(s): 68727-745